Pages that link to "Q421862"
Jump to navigation
Jump to search
The following pages link to ribavirin (Q421862):
Displaying 50 items.
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- hepatitis (Q131742) (← links)
- liver cirrhosis (Q147778) (← links)
- hepatitis C (Q154869) (← links)
- zidovudine (Q198504) (← links)
- Rift Valley fever (Q326638) (← links)
- hepatitis E (Q326643) (← links)
- didanosine (Q422606) (← links)
- stavudine (Q423984) (← links)
- Crimean-Congo hemorrhagic fever (Q1077505) (← links)
- human parainfluenza (Q2051533) (← links)
- Argentine hemorrhagic fever (Q2583514) (← links)
- Bolivian hemorrhagic fever (Q2700304) (← links)
- severe fever with thrombocytopenia syndrome (Q3508725) (← links)
- Brazilian hemorrhagic fever (Q4958833) (← links)
- hemorrhagic fever with renal syndrome (Q9002005) (← links)
- Eastern equine encephalitis (Q18553951) (← links)
- Western equine encephalitis (Q18553953) (← links)
- respiratory syncytial virus infectious disease (Q18554367) (← links)
- pharyngoconjunctival fever (Q18554607) (← links)
- West Nile encephalitis (Q18555063) (← links)
- Inosine monophosphate dehydrogenase 2 (Q21119156) (← links)
- Inosine monophosphate dehydrogenase 1 (Q21119157) (← links)
- Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis (Q21132564) (← links)
- Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro (Q21142648) (← links)
- The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis (Q21245094) (← links)
- NIOSH Method 5027: Ribavirin (Q21761870) (← links)
- response to ribavirin (Q22274464) (← links)
- NIOSH Health and Safety Practices Survey of Healthcare Workers: training and awareness of employer safety procedures (Q23909873) (← links)
- Aerosolized ribavirin - exposures and controls (Q23911906) (← links)
- Evaluation of respirator performance against aerosolized ribavirin in a health care setting (Q23911907) (← links)
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C (Q24200189) (← links)
- Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients (Q24200534) (← links)
- Protease inhibitors in combination with pegylated interferon and ribavirin for adult patients with chronic hepatitis C virus (Q24202464) (← links)
- Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Q24235515) (← links)
- Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks for patients with chronic hepatitis C virus genotype 1 infection having shown slow antiviral response (Q24235606) (← links)
- Ribavirin monotherapy for chronic hepatitis C (Q24240057) (← links)
- Ribavirin plus interferon versus interferon for chronic hepatitis C (Q24240879) (← links)
- Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C (Q24241360) (← links)
- Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Q24242993) (← links)
- Ribavirin plus interferon versus interferon for chronic hepatitis C (Q24244070) (← links)
- Ribavirin monotherapy for chronic hepatitis C (Q24245444) (← links)
- Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children (Q24246151) (← links)
- Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C (Q24246836) (← links)
- Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action (Q24276089) (← links)
- Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities (Q24316273) (← links)
- The use of oral ribavirin in the management of La Crosse viral infections (Q24531561) (← links)
- Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection (Q24538772) (← links)
- Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond? (Q24594939) (← links)
- RNA virus error catastrophe: direct molecular test by using ribavirin (Q24599371) (← links)